Merck Laying Off 150 Workers at North Carolina Site
Merck will cut 150 jobs at its North Carolina site in May after Gardasil sales fell. The move follows changes to vaccine schedules and lower demand in China.
Xurve View
Insights:
Xurve View
Merck & Co., Inc. is set to reduce its workforce by approximately 150 employees at a manufacturing facility in North Carolina. The site is responsible for producing Gardasil, the company's vaccine against human papillomavirus (HPV). This decision follows a significant downturn in global sales for the product, which was previously considered a primary growth engine for the pharmaceutical giant.
